| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/22/2009 | EP1846448B1 Diagnosis of allergic complaints, atopic diseases and/or auto-immune diseases by the identification of antibodies against cd28 in human serum |
| 07/22/2009 | EP1734986A4 Method for modulating appetite |
| 07/22/2009 | EP1713830B1 Anti-epcam immunoglobulins |
| 07/22/2009 | EP1706424B1 Fc region variants |
| 07/22/2009 | EP1592704B1 Leukocyte stimulating peptides |
| 07/22/2009 | EP1288661B1 Method for examining wt1-related disease |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP0954326B2 A process for viral inactivation of lyophilized blood proteins |
| 07/22/2009 | EP0873135B1 Peanut allergens and methods |
| 07/22/2009 | CN101490088A Methods and compositions for targeting HEPSIN |
| 07/22/2009 | CN101490087A Antibodies and immunoconjugates and uses therefor |
| 07/22/2009 | CN101490086A Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody |
| 07/22/2009 | CN101490085A Single-chain multivalent binding proteins with effector function |
| 07/22/2009 | CN101490084A Anti-dll4 antibodies and methods using same. |
| 07/22/2009 | CN101490083A Small streptococcus pyogenes antigens and their use |
| 07/22/2009 | CN101486767A Mercury resistant chelate monoclonal antibody, as well as preparation method and application thereof |
| 07/22/2009 | CN101486766A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 07/22/2009 | CN101486765A Harmful algal bloom biological cell surface specific antibody and preparation thereof |
| 07/22/2009 | CN101486759A Human Toll-like receptor protein, related reagent and method |
| 07/22/2009 | CN101486756A Outer surface proteins, their genes, and their use |
| 07/22/2009 | CN100516222C Variable region of monoclonal antibody against HBV S-surface antigene and gene encoding same |
| 07/22/2009 | CN100516210C Antibody for detecting mycoplasma pheumoniae |
| 07/22/2009 | CN100516086C Purification of immunoglobulins |
| 07/22/2009 | CN100515495C Lyophilized preparation containing antibodies to the EGF receptor |
| 07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
| 07/21/2009 | US7563880 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/21/2009 | US7563879 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563874 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/21/2009 | US7563869 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases |
| 07/21/2009 | US7563867 PRO4356 polypeptides |
| 07/21/2009 | US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 07/21/2009 | US7563775 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/21/2009 | US7563770 Pharmacokinetics; chemical stability; gene therapy |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563599 Reshaped human antibody to human medulloblastoma cells |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563568 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | US7563446 Administering a phosphatidylserine/polypeptide conjugate with polypeptide being bovine serum albumin, keyhole limpet hemocyanin, bovine gamma-globulin, diphtheria toxin, or beta 2-glycoprotein |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563444 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/21/2009 | US7563443 Comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD40L without substantially agonizing CD40 activity; Polyethylene Glycol-linked antibody single variable domain polypeptide |
| 07/21/2009 | US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
| 07/21/2009 | US7563441 Anti-P-selectin antibodies |
| 07/21/2009 | US7563440 vaccination against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/21/2009 | US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy |
| 07/21/2009 | US7563438 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/16/2009 | WO2009089535A2 Polypeptide vaccine and vaccination strategy against mycobacterium |
| 07/16/2009 | WO2009089399A2 Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection |
| 07/16/2009 | WO2009089295A2 Anti-hiv domain antibodies and method of making and using same |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | WO2009089062A2 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders |
| 07/16/2009 | WO2009089004A1 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| 07/16/2009 | WO2009088949A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | WO2009088928A2 Libraries, arrays and their uses for targeted affinity enhancement |
| 07/16/2009 | WO2009088924A2 Methods and materials for targeted affinity enhancement |
| 07/16/2009 | WO2009088753A1 Isomerases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | WO2009088694A1 Methods for detection of cyclosporin a |
| 07/16/2009 | WO2009088159A1 Antibodies to respiratory syncytial virus |
| 07/16/2009 | WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF |
| 07/16/2009 | WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088032A1 Antibody directed against pcrv |
| 07/16/2009 | WO2009087978A1 Anti-cldn6 antibody |
| 07/16/2009 | WO2009087467A2 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 07/16/2009 | WO2009087462A2 Ephrin type-a receptor 10 protein |
| 07/16/2009 | WO2009087173A2 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
| 07/16/2009 | WO2009086920A1 Anti mif antibodies |
| 07/16/2009 | WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | WO2009067242A3 Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof |
| 07/16/2009 | WO2009043057A3 Cell rolling separation |
| 07/16/2009 | WO2008099185A8 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/16/2009 | WO2008094942A8 Humanized antibodies against cxcr3 |
| 07/16/2009 | WO2008044068A8 Combination therapy |
| 07/16/2009 | WO2008043145A8 Hybridomas producing antibodies against non functional p2x7 receptor |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | WO2008039553A8 Soluble il-17rcx4 and methods of using in inflammation |
| 07/16/2009 | WO2008001045A8 Members of the glycoside hydrolase family 31 family of proteins |
| 07/16/2009 | WO2008000028A8 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 07/16/2009 | WO2007148095A8 Methods for determining a prognosis of colorectal cancer |
| 07/16/2009 | WO2004055164A3 System and method for stabilizing antibodies with histidine |
| 07/16/2009 | WO2003051720A3 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
| 07/16/2009 | US20090183280 Transgenic Plants Modified for Reduced Cadmium Transport, Derivative Products, and Related Methods |
| 07/16/2009 | US20090182127 Production of Bispecific Antibodies |
| 07/16/2009 | US20090182126 Guanylate-binding protein |
| 07/16/2009 | US20090182120 Surface mediated self-assembly of nanoparticles |
| 07/16/2009 | US20090182038 Leptomycin Derivatives |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181900 Novel peptides and methods for the treatment of inflammatory disease |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181891 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/16/2009 | US20090181884 Novel apolipoprotein gene involved in lipid metabolism |
| 07/16/2009 | US20090181859 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes |
| 07/16/2009 | US20090181855 Rationally Designed, Synthetic Antibody Libraries and Uses Therefor |
| 07/16/2009 | US20090181410 Immunoglobulin peptides against asian pangasius catfish |
| 07/16/2009 | US20090181116 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of novel delta-endotoxin genes and methods for their use |